{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:57:24Z","timestamp":1793318244952,"version":"4.5.0"},"reference-count":48,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006636","name":"The Swedish Research Council for Health, Working Life and Welfare","doi-asserted-by":"publisher","award":["2022-00643"],"award-info":[{"award-number":["2022-00643"]}],"id":[{"id":"10.13039\/501100006636","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Linnaeus University Centre for Data Intensive Sciences and Applications","award":["2022-00643"],"award-info":[{"award-number":["2022-00643"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>Adverse drug events (ADEs) occur frequently and are a common cause of suffering, hospitalizations, or death, and can be caused by harmful combinations of medications. One method used to prevent ADEs is by using clinical decision support systems (CDSSs). Janusmed Risk Profile is a CDSS evaluating the risk for nine common or serious ADEs resulting from combined pharmacodynamic effects. The aim of this study was to examine the prevalence of potential ADEs identified using CDSS algorithms from Janusmed Risk Profile. This retrospective, cross-sectional study covered the population of a Swedish region (n = 246,010 inhabitants in year 2020) using data on all medications dispensed and administered. More than 20% of patients had an increased risk of bleeding, constipation, orthostatism, or renal toxicity based on their medications. The proportion of patients with an increased risk varied from 3.5% to almost 30% across the nine categories of ADEs. A higher age was associated with an increased risk of potential ADEs and there were gender differences. A cluster analysis identified groups of patients with an increased risk for several categories of ADEs. This study shows that combinations of medications that could increase the risk of ADEs are common. Future studies should examine how this correlates with observed ADEs.<\/jats:p>","DOI":"10.3390\/pharmacy12060168","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T04:47:17Z","timestamp":1731646037000},"page":"168","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Potential Adverse Drug Events Identified with Decision Support Algorithms from Janusmed Risk Profile\u2014A Retrospective Population-Based Study in a Swedish Region"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1549-2469","authenticated-orcid":false,"given":"Tora","family":"Hammar","sequence":"first","affiliation":[{"name":"The eHealth Institute, Department of Medicine and Optometry, Linnaeus University, S-391 82 Kalmar, Sweden"},{"name":"Linnaeus University Centre for Data Intensive Sciences and Applications (LnuC DISA), Department of Computer Science and Media Technology (CM), Faculty of Technology, Linnaeus University, S-391 82 Kalmar, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Jons\u00e9n","sequence":"additional","affiliation":[{"name":"The eHealth Institute, Department of Medicine and Optometry, Linnaeus University, S-391 82 Kalmar, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8370-2950","authenticated-orcid":false,"given":"Olof","family":"Bj\u00f6rneld","sequence":"additional","affiliation":[{"name":"The eHealth Institute, Department of Medicine and Optometry, Linnaeus University, S-391 82 Kalmar, Sweden"},{"name":"Linnaeus University Centre for Data Intensive Sciences and Applications (LnuC DISA), Department of Computer Science and Media Technology (CM), Faculty of Technology, Linnaeus University, S-391 82 Kalmar, Sweden"},{"name":"Business Intelligence, IT Division, Region Kalmar County, S-392 32 Kalmar, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylva","family":"Askfors","sequence":"additional","affiliation":[{"name":"The eHealth Institute, Department of Medicine and Optometry, Linnaeus University, S-391 82 Kalmar, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2592-9863","authenticated-orcid":false,"given":"Marine L.","family":"Andersson","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institute and Clinical Pharmacology, Medical Diagnostics Karolinska, Karolinska University Hospital, S-141 86 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9062-1609","authenticated-orcid":false,"given":"Alisa","family":"Lincke","sequence":"additional","affiliation":[{"name":"Linnaeus University Centre for Data Intensive Sciences and Applications (LnuC DISA), Department of Computer Science and Media Technology (CM), Faculty of Technology, Linnaeus University, S-391 82 Kalmar, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00228-014-1745-3","article-title":"A limited number of prescribed drugs account for the great majority of drug-drug interactions","volume":"70","author":"Holm","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_2","unstructured":"Hakkarainen, K.M. (2014). Prevalence and Nature of Adverse Drug Events and the Potential for Their Prevention\u2014Population-Based Studies Among Adults. [Ph.D. Thesis, Sahlgrenska Academy at University of Gothenburg]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13561-024-00481-y","article-title":"Evaluating the costs of adverse drug events in hospitalized patients: A systematic review","volume":"14","author":"Durand","year":"2024","journal-title":"Health Econ. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00228-017-2330-3","article-title":"The prevalence of medication-related adverse events in inpatients-a systematic review and meta-analysis","volume":"73","author":"Laatikainen","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-140-10-200405180-00009","article-title":"Clarifying adverse drug events: A clinician\u2019s guide to terminology, documentation, and reporting","volume":"140","author":"Nebeker","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.mpaic.2014.04.005","article-title":"Mechanisms of drug interactions: Pharmacodynamics and pharmacokinetics","volume":"15","author":"Corrie","year":"2014","journal-title":"Anaesth. Intensive Care Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/pds.5691","article-title":"A meta-analysis assessing the prevalence of drug-drug interactions among hospitalized patients","volume":"32","author":"Aksoy","year":"2023","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Gonzaga de Andrade Santos, T.N., Mendon\u00e7a da Cruz Macieira, G., Cardoso Sodr\u00e9 Alves, B.M., Onozato, T., Cunha Cardoso, G., Ferreira Nascimento, M.T., Saquete Martins-Filho, P.R., Pereira de Lyra, D., and Oliveira Filho, A.D. (2020). Prevalence of clinically manifested drug interactions in hospitalized patients: A systematic review and meta-analysis. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0235353"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pds.3592","article-title":"Hospital admissions\/visits associated with drug-drug interactions: A systematic review and meta-analysis","volume":"23","author":"Dechanont","year":"2014","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMsa2206117","article-title":"The Safety of Inpatient Health Care","volume":"388","author":"Bates","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/bcp.14139","article-title":"Preventable adverse drug events: Descriptive epidemiology","volume":"86","author":"Woo","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjqs-2019-010436","article-title":"Effects of CPOE-based medication ordering on outcomes: An overview of systematic reviews","volume":"29","author":"Abraham","year":"2020","journal-title":"BMJ Qual. Saf."},{"key":"ref_13","unstructured":"Jao, C.S. (2010). Knowledge Bases for Clinical Decision Support in Drug Prescribing\u2014Development, Quality Assurance, Management, Integration, Implementation and Evaluation of Clinical Value. Decision Support Systems, InTech."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s40264-024-01412-w","article-title":"Drug-Drug Interactions and Actual Harm to Hospitalized Patients: A Multicentre Study Examining the Prevalence Pre- and Post-Electronic Medication System Implementation","volume":"47","author":"Li","year":"2024","journal-title":"Drug Saf. Int. J. Med. Toxicol. Drug Exp."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(23)02465-0","article-title":"The effect of computerised decision support alerts tailored to intensive care on the administration of high-risk drug combinations, and their monitoring: A cluster randomised stepped-wedge trial","volume":"403","author":"Bakker","year":"2024","journal-title":"Lancet"},{"key":"ref_16","unstructured":"Region of Stockholm (2024, October 31). Janusmed Knowledge Databases. Available online: https:\/\/janusinfo.se\/."},{"key":"ref_17","first-page":"1500","article-title":"Evaluating a Clinical Decision Support System for Drug-Drug Interactions","volume":"264","author":"Jalali","year":"2019","journal-title":"Stud. Health Technol. Inform."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00228-008-0612-5","article-title":"SFINX\u2014A drug-drug interaction database designed for clinical decision support systems","volume":"65","author":"Laine","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/17512433.2020.1805314","article-title":"Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: Report by an international expert workshop at Karolinska Institutet","volume":"13","author":"Hoffmann","year":"2020","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/amiajnl-2013-001813","article-title":"Overrides of medication-related clinical decision support alerts in outpatients","volume":"21","author":"Nanji","year":"2014","journal-title":"J. Am. Med. Inform. Assoc. JAMIA"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Coleman, J.J., van der Sijs, H., Haefeli, W.E., Slight, S.P., McDowell, S.E., Seidling, H.M., Eiermann, B., Aarts, J., Ammenwerth, E., and Ferner, R.E. (2013). On the alert: Future priorities for alerts in clinical decision support for computerized physician order entry identified from a European workshop. BMC Med. Inform. Decis. Mak., 13.","DOI":"10.1186\/1472-6947-13-122"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Van De Sijpe, G., Quintens, C., Walgraeve, K., Van Laer, E., Penny, J., De Vlieger, G., Schrijvers, R., De Munter, P., Foulon, V., and Casteels, M. (2022). Overall performance of a drug-drug interaction clinical decision support system: Quantitative evaluation and end-user survey. BMC Med. Inform. Decis. Mak., 22.","DOI":"10.1186\/s12911-022-01783-z"},{"key":"ref_23","first-page":"380","article-title":"Overriding Drug-Drug Interaction Alerts in Clinical Decision Support Systems: A Scoping Review","volume":"290","author":"Subbian","year":"2022","journal-title":"Stud. Health Technol. Inform."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"104393","DOI":"10.1016\/j.ijmedinf.2021.104393","article-title":"Evaluation of an optimized context-aware clinical decision support system for drug-drug interaction screening","volume":"148","author":"Muylle","year":"2021","journal-title":"Int. J. Med. Inform."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00228-017-2391-3","article-title":"Development and pilot testing of PHARAO-a decision support system for pharmacological risk assessment in the elderly","volume":"74","author":"Bottiger","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Hedna, K., Andersson, M.L., Gyllensten, H., H\u00e4gg, S., and B\u00f6ttiger, Y. (2019). Clinical relevance of alerts from a decision support system, PHARAO, for drug safety assessment in the older adults. BMC Geriatr., 19.","DOI":"10.1186\/s12877-019-1179-y"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s40266-023-01021-9","article-title":"Pharmacological Risk Assessment Among Older Patients with Polypharmacy Using the Clinical Decision Support System Janusmed Risk Profile: A Cross-Sectional Register Study","volume":"40","author":"Petersson","year":"2023","journal-title":"Drugs Aging"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/jama.1995.03530010043033","article-title":"Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group","volume":"274","author":"Bates","year":"1995","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Fahrni, M.L., Azmy, M.T., Usir, E., Aziz, N.A., and Hassan, Y. (2019). Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: A multicentre, prospective study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0219898"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e2236757","DOI":"10.1001\/jamanetworkopen.2022.36757","article-title":"Performance of 3 Sets of Criteria for Potentially Inappropriate Prescribing in Older People to Identify Inadequate Drug Treatment","volume":"5","author":"Wallerstedt","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.3399\/BJGP.2020.1048","article-title":"Prevalence and predictors of potentially inappropriate prescribing in middle-aged adults: A repeated cross-sectional study","volume":"71","author":"Khatter","year":"2021","journal-title":"Br. J. Gen. Pract."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Habib, B., Tamblyn, R., Girard, N., Eguale, T., and Huang, A. (2021). Detection of adverse drug events in e-prescribing and administrative health data: A validation study. BMC Health Serv. Res., 21.","DOI":"10.1186\/s12913-021-06346-y"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e5880","DOI":"10.1002\/pds.5880","article-title":"Prevalence of Polypharmacy in Elderly Population Worldwide: A Systematic Review and Meta-Analysis","volume":"33","author":"Wang","year":"2024","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"105465","DOI":"10.1016\/j.archger.2024.105465","article-title":"Global and regional prevalence of polypharmacy and related factors, 1997-2022: An umbrella review","volume":"124","author":"Kim","year":"2024","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register\u2014Opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00357-001-0004-3","article-title":"K-modes Clustering","volume":"18","author":"Chaturvedi","year":"2001","journal-title":"J. Classif."},{"key":"ref_37","first-page":"17","article-title":"EBK-Means: A Clustering Technique based on Elbow Method and K-Means in WSN","volume":"105","author":"Bholowalia","year":"2014","journal-title":"Int. J. Comput. Appl."},{"key":"ref_38","unstructured":"de Vos, N.J. (2024, October 05). Kmodes Categorical Clustering Library. Available online: https:\/\/github.com\/nicodv\/kmodes."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/jcpt.12854","article-title":"Clinically relevant drug-drug interactions and the risk for drug adverse effects among home-dwelling older persons with and without type 2 diabetes","volume":"44","author":"Karjalainen","year":"2019","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_40","first-page":"294","article-title":"Patient Characteristics Associated with Adverse Drug Events in Hospital: An Overview of Reviews","volume":"69","author":"Mihajlovic","year":"2016","journal-title":"Can. J. Hosp. Pharm."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Valle, J., Correia, R.B., Camacho-Artacho, M., Lepore, R., Mattos, M.M., Rocha, L.M., and Valencia, A. (2024). Prevalence and differences in the co-administration of drugs known to interact: An analysis of three distinct and large populations. BMC Med., 22.","DOI":"10.1186\/s12916-024-03384-1"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","article-title":"Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews","volume":"21","author":"Davies","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2146\/ajhp160830","article-title":"Improving medication-related clinical decision support","volume":"75","author":"Tolley","year":"2018","journal-title":"Am. J. Health-Syst. Pharm. AJHP"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e19489","DOI":"10.2196\/19489","article-title":"Machine Learning Approach to Reduce Alert Fatigue Using a Disease Medication-Related Clinical Decision Support System: Model Development and Validation","volume":"8","author":"Poly","year":"2020","journal-title":"JMIR Med. Inform."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4140\/TCP.n.2019.317","article-title":"Discrepancies Between the Medication List in Electronic Prescribing Systems and Patients\u2019 Actual Use of Medicines","volume":"34","author":"Treldal","year":"2019","journal-title":"Sr. Care Pharm."},{"key":"ref_46","first-page":"207","article-title":"Nationally Shared Medication Lists\u2014Describing Systems in the Nordic Countries","volume":"302","author":"Hammar","year":"2023","journal-title":"Stud. Health Technol. Inform."},{"key":"ref_47","first-page":"287","article-title":"Challenges with Medication Management and the National Medication List in Sweden: An Interview Study from a Human, Organizational, and Technology Perspective","volume":"302","author":"Hammar","year":"2023","journal-title":"Stud. Health Technol. Inform."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00228-021-03238-2","article-title":"Hospitalizations and deaths related to adverse drug events worldwide: Systematic review of studies with national coverage","volume":"78","author":"Silva","year":"2022","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/12\/6\/168\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:32:44Z","timestamp":1760113964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/12\/6\/168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["pharmacy12060168"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy12060168","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]}}}